+49 (0)511 532 8736 Email: viejo-borbolla.abel @ mh-hannover.de About me (Abel Viejo-Borbolla): I studied Biological Sciences (specialized in Molecular Biology and Biochemistry) at the “Universidad Autónoma [...] my PhD research was to improve targeted retroviral vectors used in gene therapy. Then I started studying herpesviruses, working first with Kaposi’s sarcoma-associated herpesvirus in Thomas Schulz’s lab [...] l Virology and in 2019 I became an APL Professor. One of the best things of my career is that I studied and worked in very different environments in different countries. This allowed me to meet incredible

patients with progressive myocardial insufficiency because of myocardial infarction. In previous studies, the cells were injected manually into the recipient heart. In order to allow an optimized and b [...] the preclinical implementation of new cell therapy concepts, a review of the data from in vitro studies in the living organism is inevitable. Only suitable animal models allow such therapeutic applications [...] knowledge, preclinical testing of our therapeutic concept is only possible in non-human primates. Our studies in rhesus monkeys will be performed at the German Primate Center in Göttingen according to strict

original paper can only be granted to those who have contributed substantially to the conception of the study or experiments, to the production, analysis or interpretation of data or to the writing of the manuscript [...] person has to be a faculty member of the MHH. Exceptionally, the “Dean of Research” or the “Dean of Study” can be elected by the Senate for this position. The duties of the Ombudsfrau/mann are: confidentially

be able to link genuine basic biochemical research with translational application. "I originally studied pharmacy, and the development of substances that can ideally actually be used on patients one day

"Palliative Medicine," and "Laboratory Diagnostics in Internal Medicine." She has led over 20 clinical studies and is listed on the scientific data portal PubMed with more than 150 publications. “This perfor

ACT-COVID19-Study A Phase I/ Randomized Phase II Trial To Analyse Safety And Efficacy Of Human SARS-COV-2-Specific T Lymphocyte Transfer In Patients With COVID-19 In Need Of Treatment Or At Risk Of Severe

tracking of the cells in not only preclinical animal models but later also in patients. In the present study, the research team led by Professor Dr. Ulrich Martin - in collaboration with a group from Zürich

the resolution in this area of the capsid is not sufficient for this," explains Thomas Krey. In the study results now published, the researchers were able to prove that the portal cap protein (pORF19) also

01.10.2021 The start has been a success: today, Friday, 28 students began their midwifery studies at the Hannover Medical School (MHH). Professor Dr. Mechthild Groß, head midwife and acting head of the

Clinical Transfusion Medicine Further information: Prof. Dr. Stephan Immenschuh T +49 (511) 532 6704 Study and training courses Medicine Human Medicine - Hanover Medical School General information on the medical